Rankings
▼
Calendar
FBLG Q2 2022 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
$17M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$911,000
Net Income
-$1M
EPS (Diluted)
$-0.04
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$763
Free Cash Flow
-$763
Stock-Based Comp.
$84
← FY 2022
All Quarters
Q3 2022 →
